FLT3-ITD promotes immune checkpoint CD80 via ROS elevation in acute myeloid leukemia
Acute myeloid leukemia (AML), a malignant hematological stem cell disease, arises from the malignant transformation of myeloid progenitor cells. Among the genetic aberrations in AML, mutations in the tyrosine kinase receptor FLT3, especially FLT3-ITD, …